sunitinib maleate

Poland

Drugs containing this active substance

  • SUGANET

    The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are in a progressive phase and cannot be surgically removed.

    Form: capsules, hard

    Active substance Dosage
    sunitinib maleate 16.71 mg

    ATC: L01EX01

    Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.

  • SUGANET

    The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are in the progressive phase and cannot be surgically removed.

    Form: capsules, hard

    Active substance Dosage
    sunitinib maleate 33.41 mg

    ATC: L01EX01

    Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.

  • SUGANET

    The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are in the progressive stage and cannot be surgically removed.

    Form: capsules, hard

    Active substance Dosage
    sunitinib maleate 66.83 mg

    ATC: L01EX01

    Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.

  • SUNITINIB ADAMED

    The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma, and pancreatic neuroendocrine tumors (pNET) that are in the progressive phase and cannot be surgically removed.

    Form: capsules, hard

    Active substance Dosage
    sunitinib maleate 16.7063 mg

    ATC: L01EX01

    Manufacturer: Adamed Pharma S.A. Tecnimede - Sociedade Técnico-Medicinal S.A.

  • SUNITINIB ADAMED

    The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are in the progressive stage and cannot be surgically removed.

    Form: capsules, hard

    Active substance Dosage
    sunitinib maleate 33.4126 mg

    ATC: L01EX01

    Manufacturer: Adamed Pharma S.A. Tecnimede - Sociedade Técnico-Medicinal S.A.

  • SUNITINIB ADAMED

    The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are in the progressive phase and cannot be surgically removed.

    Form: capsules, hard

    Active substance Dosage
    sunitinib maleate 50.1189 mg

    ATC: L01EX01

    Manufacturer: Adamed Pharma S.A. Tecnimede - Sociedade Técnico-Medicinal S.A.

  • SUNITINIB ADAMED

    The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are in the progressive phase and cannot be surgically removed.

    Form: capsules, hard

    Active substance Dosage
    sunitinib maleate 66.825 mg

    ATC: L01EX01

    Manufacturer: Adamed Pharma S.A. Tecnimede - Sociedade Técnico-Medicinal S.A.

  • SUNITINIB SANEXCEL

    The medicine is used in adults for the treatment of gastrointestinal stromal tumor (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET).

    Form: capsules, hard

    Active substance Dosage
    sunitinib maleate 33.4126 mg

    ATC: L01EX01

    Manufacturer: Tecnimede - Sociedade Técnico-Medicinal S.A.

  • SUNITINIB SANEXCEL

    The medicine is used in adults for the treatment of gastrointestinal stromal tumor (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET).

    Form: capsules, hard

    Active substance Dosage
    sunitinib maleate 66.825 mg

    ATC: L01EX01

    Manufacturer: Tecnimede - Sociedade Técnico-Medicinal S.A.

  • SUNITINIB SYNTHON

    The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) (in the progressive stage or when they cannot be surgically removed).

    Form: capsules, hard

    Active substance Dosage
    sunitinib maleate 16.71 mg

    ATC: L01EX01

    Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.

  • SUNITINIB SYNTHON

    The medicine is used in adults for the treatment of gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET).

    Form: capsules, hard

    Active substance Dosage
    sunitinib maleate 33.41 mg

    ATC: L01EX01

    Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.

  • SUNITINIB SYNTHON

    The medicine is used in adults for the treatment of specific types of cancer: gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET).

    Form: capsules, hard

    Active substance Dosage
    sunitinib maleate 66.83 mg

    ATC: L01EX01

    Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.

  • SUNITINIB VIPHARM

    The medicine is used in adults for the treatment of cancers: gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are in the progressive phase and cannot be surgically removed.

    Form: capsules, hard

    Active substance Dosage
    sunitinib maleate 16.7 mg

    ATC: L01EX01

    Manufacturer: Vipharm S.A.

  • SUNITINIB VIPHARM

    The medicine is used in adults to treat specific types of cancer: gastrointestinal stromal tumors (GIST), metastatic renal cell carcinoma (mRCC), and pancreatic neuroendocrine tumors (pNET) that are progressing and cannot be surgically removed.

    Form: capsules, hard

    Active substance Dosage
    sunitinib maleate 33.4 mg

    ATC: L01EX01

    Manufacturer: Vipharm S.A.